Microbiome in cancer resistance and combating strategies Microbiome in cancer resistance The tumor microbiome, encompassing bacteria, fungi, viruses, and mycoplasma, has emerged as a key modulator of tumor progression and therapeutic response (Fig
Of the cohort studies already included above 187,190,192 , two report additional results of relevance
When to stop or reconsider GLP-1 therapy Not every Hashimoto's patient should stay on GLP-1 medications indefinitely
Growth hormone and IGF-1 are also fundamental in skeletal growth during puberty, namely given that IGF-1 causes increased uptake of amino acids and nutrients, in particular collagen
Outcomes depend on eligibility, prescribing decisions, dosing, adherence, and individual response
Other similar weight loss drugs like Mounjaro or Saxenda are also GLP-1 RAs, but they have different active ingredients